New pyrazolopyridine derivatives are p38 kinase inhibitors useful in medicaments for the treatment or prevention of e.g. cardiovascular diseases, neurodegenerative diseases and proliferative diseases
New compounds of formula (I) and the salts thereof, wherein the meanings for the various substituents are as disclosed in the description, are useful as p38 kinase inhibitors.